EMERGENCY PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION IN PATIENTS 70 YEARS OF AGE AND OLDER

被引:52
作者
LEE, TC [1 ]
LARAMEE, LA [1 ]
RUTHERFORD, BD [1 ]
MCCONAHAY, DR [1 ]
JOHNSON, WL [1 ]
GIORGI, LV [1 ]
LIGON, RW [1 ]
HARTZLER, GO [1 ]
机构
[1] ST LUKES HOSP, CARDIOVASC CONSULTANTS INC, MID AMER HEART INST, 4320 WORNALL RD, KANSAS CITY, MO 64111 USA
关键词
D O I
10.1016/0002-9149(90)91126-Q
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Direct percutaneous transluminal coronary angioplasty (PTCA) was performed as the primary means of establishing reperfusion during acute myocardial infarction in 105 elderly patients (mean age ± standard deviation 75 ± 4 years) at a mean of 5.5 ± 4.0 hours from symptom onset. Fifty-two patients (50%) had anterior infarctions, 70 (67%) had significant narrowing in >1 vessel, and 12 (11%) were in cardiogenic shock. Primary success was achieved in 91% of the infarct-related arteries. Four patients with failed PTCA underwent emergency bypass surgery; 10 had early symptomatic reocclusion of the dilated vessel. There was 1 death acutely in the catheterization laboratory. The overall in-hospital mortality was 18%. Three-vessel coronary artery disease and cardiogenic shock on presentation were the strongest predictors of inhospital death. Global ejection fraction improved from 54 ± 13 to 61 ± 15% (p < 0.001). The 1- and 5-year survival rates, including in-hospital deaths, were 73 and 67%, respectively. It is concluded that direct PTCA is an effective means of salvaging ischemie myocardium during acute myocardial infarction in the elderly patient. It is associated with a high success rate and low complication rate. The short- and long-term survival in this high-risk group of patients are improved compared with survival rates in historical controls. © 1990.
引用
收藏
页码:663 / 667
页数:5
相关论文
共 26 条
[1]   1ST MYOCARDIAL-INFARCTION - AGE AND EJECTION FRACTION IDENTIFY A LOW-RISK GROUP [J].
AHNVE, S ;
GILPIN, E ;
DITTRICH, H ;
NICOD, P ;
HENNING, H ;
CARLISLE, J ;
ROSS, J .
AMERICAN HEART JOURNAL, 1988, 116 (04) :925-932
[2]  
[Anonymous], 1986, LANCET, V1, P397
[3]  
[Anonymous], 1989, NEW ENGL J MED, V320, P618
[4]   THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION (TAMI-1) TRIAL - INFLUENCE OF INFARCT LOCATION ON ARTERIAL PATENCY, LEFT-VENTRICULAR FUNCTION AND MORTALITY [J].
BATES, ER ;
CALIFF, RM ;
STACK, RS ;
ARONSON, L ;
GEORGE, BS ;
CANDELA, RJ ;
KEREIAKES, DJ ;
ABBOTTSMITH, CW ;
ANDERSON, L ;
PITT, B ;
ONEILL, WW ;
TOPOL, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (01) :12-18
[5]   THE USE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION IN THE ELDERLY - RESULTS FROM THROMBOLYSIS IN MYOCARDIAL-INFARCTION PHASE-I, OPEN LABEL STUDIES AND THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION PHASE-II PILOT-STUDY [J].
CHAITMAN, BR ;
THOMPSON, B ;
WITTRY, MD ;
STUMP, D ;
HAMILTON, WP ;
HILLIS, LD ;
DWYER, JG ;
SOLOMON, RE ;
KNATTERUD, GL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (05) :1159-1165
[6]   THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].
CHESEBRO, JH ;
KNATTERUD, G ;
ROBERTS, R ;
BORER, J ;
COHEN, LS ;
DALEN, J ;
DODGE, HT ;
FRANCIS, CK ;
HILLIS, D ;
LUDBROOK, P ;
MARKIS, JE ;
MUELLER, H ;
PASSAMANI, ER ;
POWERS, ER ;
RAO, AK ;
ROBERTSON, T ;
ROSS, A ;
RYAN, TJ ;
SOBEL, BE ;
WILLERSON, J ;
WILLIAMS, DO ;
ZARET, BL ;
BRAUNWALD, E .
CIRCULATION, 1987, 76 (01) :142-154
[7]   CORONARY ANGIOPLASTY AS PRIMARY THERAPY FOR ACUTE MYOCARDIAL-INFARCTION 6 TO 48 HOURS AFTER SYMPTOM ONSET - REPORT OF AN INITIAL EXPERIENCE [J].
ELLIS, SG ;
ONEILL, WW ;
BATES, ER ;
WALTON, JA ;
NABEL, EG ;
TOPOL, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (05) :1122-1126
[8]   THE RISK OF REPERFUSION STRATEGIES IN THE TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J].
FAXON, DP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (06) :A52-A57
[9]   A CLINICOPATHOLOGICAL STUDY OF PATIENTS WITH HEMORRHAGIC MYOCARDIAL-INFARCTION TREATED WITH SELECTIVE CORONARY THROMBOLYSIS WITH UROKINASE [J].
FUJIWARA, H ;
ONODERA, T ;
TANAKA, M ;
FUJIWARA, T ;
WU, DJ ;
KAWAI, C ;
HAMASHIMA, Y .
CIRCULATION, 1986, 73 (04) :749-757
[10]   PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY - APPLICATION FOR ACUTE MYOCARDIAL-INFARCTION [J].
HARTZLER, GO ;
RUTHERFORD, BD ;
MCCONAHAY, DR .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (12) :C117-C121